Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fleur Lerebours

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Cryptogenic Ischemic Stroke in Migraine: Role of Patent Foramen OvaleCédric Gollion, Fleur Lerebours, Marianne Barbieux-Guillot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2018
Late-onset neutropenia and neurological relapse, during long-term rituximab therapy in myelin oligodendrocyte glycoprotein-antibody spectrum disorderDamien Biotti, Fleur Lerebours, Fabrice Bonneville, et al.
Cephalalgia : an International Journal of Headache|November 8, 2024
Stroke due to small-vessel disease and migraine: A case-control study of a young adult with ischemic stroke populationFaustin Cloet, Gabriel Gueyraud, Fleur Lerebours, et al.
Cephalalgia : an International Journal of Headache|November 17, 2020
Atrial fibrillation and migraine with aura in young adults with ischemic strokeCédric Gollion, Julie Gazagnes, Vincent Fabry, et al.
Headache|February 5, 2022
Migraine and large artery atherosclerosis in young adults with ischemic strokeCédric Gollion, Brigitte Guidolin, Fleur Lerebours, et al.
The Journal of Headache and Pain|August 18, 2022
Insular functional connectivity in migraine with auraCédric Gollion, Fleur Lerebours, Federico Nemmi, et al.
Journal of Neurology|June 2, 2022
Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progressionGuillaume Dorcet, Hugo Migné, Damien Biotti, et al.
Clinical Case Reports|March 5, 2020
Venetoclax with high-dose methotrexate and rituximab seem effective and well-tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case reportGuillaume Beziat, Martin Gauthier, Caroline Protin, et al.
Cephalalgia : an International Journal of Headache|March 7, 2019
Functional connectivity of hypothalamus in chronic migraine with medication overuseFleur Lerebours, Kader Boulanouar, Michèle Barège, et al.
European Journal of Neurology|April 3, 2023
Stroke phenotype in cannabis users among young adults with ischemic strokeGabriel Gueyraud, Brigitte Guidolin, Jean-Marc Olivot, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Cryptogenic Ischemic Stroke in Migraine: Role of Patent Foramen OvaleCédric Gollion, Fleur Lerebours, Marianne Barbieux-Guillot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 10, 2018
Late-onset neutropenia and neurological relapse, during long-term rituximab therapy in myelin oligodendrocyte glycoprotein-antibody spectrum disorderDamien Biotti, Fleur Lerebours, Fabrice Bonneville, et al.
Cephalalgia : an International Journal of Headache|November 8, 2024
Stroke due to small-vessel disease and migraine: A case-control study of a young adult with ischemic stroke populationFaustin Cloet, Gabriel Gueyraud, Fleur Lerebours, et al.
Cephalalgia : an International Journal of Headache|November 17, 2020
Atrial fibrillation and migraine with aura in young adults with ischemic strokeCédric Gollion, Julie Gazagnes, Vincent Fabry, et al.
Headache|February 5, 2022
Migraine and large artery atherosclerosis in young adults with ischemic strokeCédric Gollion, Brigitte Guidolin, Fleur Lerebours, et al.
The Journal of Headache and Pain|August 18, 2022
Insular functional connectivity in migraine with auraCédric Gollion, Fleur Lerebours, Federico Nemmi, et al.
Journal of Neurology|June 2, 2022
Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progressionGuillaume Dorcet, Hugo Migné, Damien Biotti, et al.
Clinical Case Reports|March 5, 2020
Venetoclax with high-dose methotrexate and rituximab seem effective and well-tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case reportGuillaume Beziat, Martin Gauthier, Caroline Protin, et al.
Cephalalgia : an International Journal of Headache|March 7, 2019
Functional connectivity of hypothalamus in chronic migraine with medication overuseFleur Lerebours, Kader Boulanouar, Michèle Barège, et al.
European Journal of Neurology|April 3, 2023
Stroke phenotype in cannabis users among young adults with ischemic strokeGabriel Gueyraud, Brigitte Guidolin, Jean-Marc Olivot, et al.
Pageof 2